Diagnostic yield of bone marrow and peripheral blood FISH panel testing in clinically suspected myelodysplastic syndromes and/or acute myeloid leukemia: a prospective analysis of 433 cases.

It is unclear how often and in what setting fluorescence in situ hybridization (FISH) panels for myelodysplastic syndrome (MDS)/acute myeloid leukemia (AML) provide additional information over metaphase cytogenetics alone. Furthermore, the usefulness of peripheral blood vs bone marrow FISH has also not been directly compared. We prospectively compared metaphase cytogenetics and FISH for -5/5q-, -7/7q-, +8, and 20q- in 433 cases of suspected MDS/AML. FISH testing was abnormal in 6 (14%) of 43 and 10 (19%) of 54 cases with fewer than 20 normal metaphases or no growth, respectively. FISH was only rarely abnormal in cases with 20 normal metaphases obtained (6/222 [2.7%]). Comparison of peripheral blood and bone marrow results in 48 cases showed abnormal peripheral blood FISH results in 18 (69%) of 26 cases with abnormal bone marrow FISH results and in 5 (23%) of 22 cases with normal bone marrow FISH results. These findings, the largest published comparison of FISH vs metaphase cytogenetics in MDS/AML, provide a rational strategy for FISH testing in peripheral blood and bone marrow.

[1]  J. Hoyer,et al.  Molecular Diagnosis in Hematopathology , 2012 .

[2]  G. Bhagat,et al.  FISH analysis in addition to G-band karyotyping: utility in evaluation of myelodysplastic syndromes? , 2010, Leukemia research.

[3]  J. Cook,et al.  Fluorescence in situ hybridization for del(5q) in myelodysplasia/acute myeloid leukemia: comparison of EGR1 vs. CSF1R probes and diagnostic yield over metaphase cytogenetics alone. , 2010, Leukemia research.

[4]  K. Reichard,et al.  Fluorescence in situ hybridization testing for -5/5q, -7/7q, +8, and del(20q) in primary myelodysplastic syndrome correlates with conventional cytogenetics in the setting of an adequate study. , 2010, American journal of clinical pathology.

[5]  P. Nguyen,et al.  Myelodysplastic syndromes , 2009, Nature Reviews Disease Primers.

[6]  O. Haus,et al.  Usefulness of classic cytogenetic testing compared to fluorescence in situ hybridization in genetic diagnosis of 58 patients with myelodysplastic syndromes. , 2009, Polskie Archiwum Medycyny Wewnetrznej.

[7]  L. Shaffer,et al.  Comprar ISCN 2009 - An International System for Human Cytogenetic Nomenclature | Marilyn L. Slovak | 9783805589857 | Karger AG , 2009 .

[8]  M. Stoler,et al.  Cell and tissue based molecular pathology , 2009 .

[9]  James R. Cook,et al.  Chapter 25 – Molecular Hematopathology , 2009 .

[10]  J. Maciejewski,et al.  Myelodysplastic syndromes with del(5q): indications and strategies for cytogenetic testing. , 2008, Cancer genetics and cytogenetics.

[11]  L. Arenillas,et al.  Fluorescence in situ hybridization improves the detection of 5q31 deletion in myelodysplastic syndromes without cytogenetic evidence of 5q- , 2008, Haematologica.

[12]  L. Pajor,et al.  Lineage-specific clonality analysis of chronic myeloproliferative disorders and myelodysplastic syndrome by human androgen receptor assay , 2008, Pathology & Oncology Research.

[13]  H. Goldschmidt,et al.  Chromosomal aberrations in 130 patients with multiple myeloma studied by interphase FISH: diagnostic and prognostic relevance. , 2006, Cancer genetics and cytogenetics.

[14]  Torsten Haferlach,et al.  Modern diagnostics in acute leukemias. , 2005, Critical reviews in oncology/hematology.

[15]  Z. Zemanová,et al.  The presence of clonal cell subpopulations in peripheral blood and bone marrow of patients with refractory cytopenia with multilineage dysplasia but not in patients with refractory anemia may reflect a multistep pathogenesis of myelodysplasia. , 2005, Leukemia research.

[16]  J. Cook.  Paraffin Section Interphase Fluorescence In Situ Hybridization in the Diagnosis and Classification of Non-Hodgkin Lymphomas , 2004, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

[17]  A. Hagemeijer,et al.  Systematic screening at diagnosis of -5/del(5)(q31), -7, or chromosome 8 aneuploidy by interphase fluorescence in situ hybridization in 110 acute myelocytic leukemia and high-risk myelodysplastic syndrome patients: concordances and discrepancies with conventional cytogenetics. , 2004, Cancer genetics and cytogenetics.

[18]  D. Neuberg,et al.  Comparison of interphase FISH and metaphase cytogenetics to study myelodysplastic syndrome: an Eastern Cooperative Oncology Group (ECOG) study. , 2003, Leukemia research.

[19]  C. Klersy,et al.  Is FISH a relevant prognostic tool in myelodysplastic syndromes with a normal chromosome pattern on conventional cytogenetics? A study on 57 patients , 2003, Leukemia.

[20]  M. Silva,et al.  Comparison of cytogenetics with FISH in 40 myelodysplastic syndrome patients. , 2002, Leukemia research.

[21]  G. Dewald,et al.  Primary myelodysplastic syndrome with normal cytogenetics: utility of 'FISH panel testing' and M-FISH. , 2002, Leukemia research.

[22]  A. Cuneo,et al.  Clinical importance of interphase cytogenetics detecting occult chromosome lesions in myelodysplastic syndromes with normal karyotype , 2001, Leukemia.